Vimarsana
Biggest News Aggregation in the World

Page 46 - Industry Classification Benchmark News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Industry Classification Benchmark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Industry Classification Benchmark Today - Breaking & Trending Today

Trust Co. of Vermont Takes $114,000 Position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) - Vimarsana News

Trust Co. of Vermont Takes $114,000 Position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Trust Co. of Vermont bought a new stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB – Get Rating) during the fourth quarter, Holdings Channel reports. The institutional investor bought 745 shares of the financial services provider’s stock, valued at approximately $114,000. Several other institutional investors have also made changes to their positions in IBB. Ahrens Investment […]

Diligent Investors LLC Acquires Shares of 1,314 iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) - Vimarsana News

Diligent Investors LLC Acquires Shares of 1,314 iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Diligent Investors LLC acquired a new stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB – Get Rating) in the fourth quarter, Holdings Channel reports. The fund acquired 1,314 shares of the financial services provider’s stock, valued at approximately $201,000. A number of other hedge funds have also recently bought and sold shares of the […]

Blue Fin Capital Inc. Increases Stock Holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) - Vimarsana News

Blue Fin Capital Inc. Increases Stock Holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Blue Fin Capital Inc. lifted its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB – Get Rating) by 30.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 16,037 shares of the financial services provider’s stock after purchasing an additional 3,721 shares during the quarter. […]

iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Sees Large Volume Increase - Vimarsana News

iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Sees Large Volume Increase

IShares Nasdaq Biotechnology ETF (NASDAQ:IBB – Get Rating) shares saw unusually-strong trading volume on Thursday . Approximately 122,277 shares traded hands during trading, a decline of 96% from the previous session’s volume of 2,891,510 shares.The stock last traded at $127.12 and had previously closed at $125.97. The stock’s fifty day simple moving average is $129.34 […]

Viracta Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update - Vimarsana News

Viracta Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update

Final Phase 1b/2 data showing promising and durable signal of efficacy for Nana-val in patients with relapsed/refractory Epstein-Barr virus-positive (EBV+)...